AARS |
16q22 |
Cytoplasm |
Autosomal Recessive |
Early-onset epileptic encephalopathy with myelination defect |
2 |
(2) |
Microcephaly with hypomyelination, epileptic encephalopathy, and spasticity |
2 |
(3) |
Autosomal Dominant |
Charcot-Marie-Tooth disease type 2N |
3 |
(4,5–7) |
Distal hereditary motor neuropathy |
1 |
(8) |
AARS2 |
6p21.1 |
Mitochondria |
Autosomal Recessive |
Leukoencephalopathy with ovarian failure |
19 |
(9–13) |
Cardiomyopathy |
2 |
(14) |
Multiple respiratory chain complex defects |
4 |
(15) |
CARS2 |
13q34 |
Mitochondria |
Autosomal Recessive |
Epileptic encephalopathy |
2 |
(16) |
Progressive myoclonic epilepsy |
2 |
(17) |
DARS |
2q21.3 |
Cytoplasm |
Autosomal Recessive |
Hypomyelination with brain stem and spinal cord involvement and leg spasticity |
2 |
(18) |
DARS2 |
1q25.1 |
Mitochondria |
Autosomal Recessive |
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation |
11 |
(19–24) |
EARS2 |
16p12.2 |
Mitochondria |
Autosomal Recessive |
Leukoencephalopathy with thalamus and brainstem involvement and high lactate |
20 |
(25–30) |
Neonatal lactic acidosis, recurrent hypoglycemia, agenesis of corpus callosum |
2 |
(31) |
Multiple respiratory chain complex defects |
3 |
(15) |
FARS2 |
6p25.1 |
Mitochondria |
Autosomal Recessive |
Hereditary spastic paraplegia |
1 |
(32) |
Alpers syndrome |
5 |
(33,34) |
Early onset epilepsy |
5 |
(35–37) |
Global delay, dysarthria and tremor |
2 |
(38) |
GARS |
7p15 |
Mitochondria and Cytoplasm |
Autosomal Recessive |
Systemic mitochondrial disease |
2 |
(39) |
Cardiomyopathy |
1 |
(15) |
Autosomal Dominant |
Charcot-Marie-Tooth disease type 2D |
4 |
(40–43) |
Distal hereditary motor neuropathy |
10 |
(40,41,43–47) |
HARS |
5q31.3 |
Cytoplasm |
Autosomal Recessive |
Usher syndrome |
1 |
(48) |
Autosomal Dominant |
Charcot-Marie-Tooth disease type 2W |
5 |
(49,50) |
Distal hereditary motor neuropathy |
2 |
(50) |
HARS2 |
5q31.3 |
Mitochondria |
Autosomal Recessive |
Perrault syndrome |
2 |
(51) |
IARS |
9q22.31 |
Cytoplasm |
Autosomal Recessive |
Prenatal growth retardation, neonatal cholestasis, muscular hypotonia, intellectual disability, infantile hepatopathy |
8 |
(52,53) |
IARS2 |
1q41 |
Mitochondria |
Autosomal Recessive |
Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome; Leigh syndrome |
4 |
(54,55) |
KARS |
16q23.1 |
Mitochondria and Cytoplasm |
Autosomal Recessive |
Nonsyndromic hearing loss (DFNB89) |
2 |
(56) |
Recessive intermediate Charcot-Marie-Tooth disease type B, dysmorphic features, developmental delay, self-abusive behavior, vestibular Schwannoma |
2 |
(57) |
Visual impairment, microcephaly, developmental delay, seizures |
2 |
(58) |
LARS |
5q32 |
Cytoplasm |
Autosomal Recessive |
Infantile hepatopathy |
4 |
(59,60) |
LARS2 |
3p21.31 |
Mitochondria |
Autosomal Recessive |
Perrault syndrome |
5 |
(61,62) |
Hydrops, lactic acidosis, sideroblastic anemia, multisystem failure |
2 |
(63) |
MARS |
12q13.3 |
Cytoplasm |
Autosomal Recessive |
Interstitial lung disease and liver disease |
7 |
(64–66) |
Autosomal Dominant |
Charcot-Marie-Tooth disease type 2U |
2 |
(67,68) |
MARS2 |
2q33.1 |
Cytoplasm |
Autosomal Recessive |
Developmental delay, sensorineural hearing loss |
2 |
(69) |
Autosomal recessive spastic ataxia with leukoencephalopathy |
2 |
(70) |
NARS2 |
11q14.1 |
Mitochondria |
Autosomal Recessive |
Alpers syndrome |
1 |
(71) |
|
|
|
|
Developmental delay, intellectual disability, epilepsy, myopathy |
6 |
(72,73) |
Nonsyndromic deafness |
1 |
(74) |
Leigh syndrome |
2 |
(74) |
PARS2 |
3p21.31 |
Mitochondria |
Autosomal Recessive |
Alpers syndrome |
2 |
(71) |
Infantile-onset developmental delay and epilepsy |
2 |
(72) |
QARS |
3p21.31 |
Cytoplasm and Mitochondria |
Autosomal Recessive |
Progressive microcephaly, cerebral-cerebellar atrophy, hypomyelination, intractable seizures, developmental delay |
6 |
(75,76) |
RARS |
5q34 |
Cytoplasm |
Autosomal Recessive |
Hypomyelination |
5 |
(77) |
RARS2 |
6q16.1 |
Mitochondria |
Autosomal Recessive |
Pontocerebellar hypoplasia |
14 |
(78–84) |
Early onset epileptic encephalopathy |
2 |
(85) |
Lactic acidosis with or without neurological symptoms (microcephaly, seizures, developmental delay) |
1 |
(86) |
Intellectual disability |
1 |
(87) |
SARS |
1p13.3 |
Cytoplasm |
Autosomal Recessive |
Intellectual disability, ataxia, microcephaly, speech impairment, aggressive behavior |
1 |
(88) |
SARS2 |
19q13.2 |
Mitochondria |
Autosomal Recessive |
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis |
2 |
(89,90) |
TARS2 |
1q21.2 |
Mitochondria |
Autosomal Recessive |
Axial hypotonia and severe psychomotor delay |
2 |
(91) |
VARS |
6p21.33 |
Cytoplasm |
Autosomal Recessive |
Severe developmental delay, microcephaly, seizures |
2 |
(92) |
VARS2 |
6p21.33 |
Mitochondria |
Autosomal Recessive |
Microcephaly and epilepsy |
1 |
(91) |
Encephalocardiomyopathy |
2 |
(93) |
Multiple respiratory chain complex defects |
2 |
(15) |
WARS |
14q32.2 |
Cytoplasm |
Autosomal Dominant |
Distal hereditary motor neuropathy |
1 |
(94) |
WARS2 |
1p12 |
Mitochondria |
Autosomal Recessive |
Intellectual disability, ataxia, microcephaly, speech impairment, aggressive behavior |
2 |
(88) |
YARS |
1p35.1 |
Cytoplasm |
Autosomal Recessive |
Multisystem disease, developmental delay, failure to thrive |
2 |
(95) |
Autosomal Dominant |
Dominant intermediate Charcot-Marie-Tooth disease type C |
5 |
(96,97) |
YARS2 |
12p11.21 |
Mitochondria |
Autosomal Recessive |
Myopathy, lactic acidosis, sideroblastic anemia, cardiomyopathy, respiratory insufficiency |
7 |
(98–103) |
|
|
|
|
Multiple respiratory chain complex defects |
1 |
(15) |